NGM Bio Outlines 2021 Strategic Priorities Across Its Three Therapeutic Area Portfolios, Including Liver and Metabolic Diseases, Retinal Diseases and Oncology

NEXT STORY
Immunovant Appoints Rita Jain Chief Medical Officer And Provides Corporate Update
PREV STORY
Merus Announces Collaborations with Nationwide Medical Organizations in the Netherlands and Japan to Enhance Screening and Identification of Cancer Patients with NRG1 Fusion Tumors and to Raise Awareness of the eNRGy Clinical Trial
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Patient Engagement Solutions Market Will Grow Over USD 48.24 Billion By 2025: Zion Market Research

author_avatar
NASDAQ Market News

Dry Powder Inhalers Market is slated to Exhibit a CAGR of Nearly 4% during the Forecast Period (2017-2026)

VALLEY COTTAGE, NY , Feb. 08, 2018 (GLOBE NEWSWIRE) -- According to Future Market ...

author_avatar
NASDAQ Market News

Reata Pharmaceuticals Announces Presentations at Upcoming Medical Conferences

author_avatar
NASDAQ Market News